This isn't a case of isolated reporting lapses the FDA found that the company's written protocols were themselves the problem
Despite this higher nominal number, Retatrutides multi-receptor activity means that its efficacy is not just a matter of dose size, but of combined GLP-1, GIP, and glucagon stimulation
Analysis of the STEP discontinuation figure also notes that it largely reflects patients managing symptoms without close physician oversight
J Orthop Surg Res 18 , 952 (2023)
Expected loss: 4-8 lbs
It is not supplied as a medicine, treatment, supplement, cosmetic product, wellness product, body composition product, weight-loss product or personal-use product